Dexpramipexole dihydrochloride
Cat. No.：YN1730076
CAS No. ：104632-27-1
| 产品名称: | Dexpramipexole dihydrochloride |
| CAS No.: | 104632-27-1 |
| Chemical Name: | 4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine, dihydrochloride |
| Synonyms: | 右旋普拉克索二盐酸盐; (R)-Pramipexole dihydrochloride; R-(+)-Pramipexole dihydrochloride; KNS-760704 dihydrochloride |
| 分子量: | 284.25 |
| 分子式: | C₁₀H₁₉Cl₂N₃S |
| SMILES: | NC(S1)=NC2=C1C[C@H](NCCC)CC2.[H]Cl.[H]Cl |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Dexpramipexole dihydrochloride ((R)-Pramipexole dihydrochloride) 是神经保护剂，是弱的非麦角类多巴胺受体激动剂。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Hametner, E.M., Seppi, K., and Poewe, W.Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's diseaseClin. Interv. Aging7,83-88(2012)
Kvernmo, T., Härtter, S., and Bürger, E.A review of the receptor-binding and pharmacokinetic properties of dopamine agonistsClin. Ther.28(8),1065-1078(2006)
Millan, M.J., Maiofiss, L., Cussac, D., et al.Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypesJ. Pharmacol. Exp. Ther.303(2),791-804(2002)
Newman-Tancredi, A., Cussac, D., Audinot, V., et al.Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D2-like receptor and α1/α2-adrenoceptorJ. Pharmacol. Exp. Ther.303(2),805-814(2002)
Danzeisen, R., Schwalenstoecker, B., Gillardon, F., et al.Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x [(+)2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-benzathiazole dihydrochloride]JPET316(1),189-199(2006)
Chang, W.I., Weber, M., Breier, M.R., et al.Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in ratsBrain Res.1437,69-76(2012)
Ferrari-Toninelli, G., Maccarinelli, G., Uberti, D., et al.Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexoleBMC Pharmacol.10(2),1-6(2010)
Abramova, N.A., Cassarino, D.S., Khan, S.M., et al.Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion orβamyloid peptide in SH-SY5Y neuroblastomaJ. Neurosci. Res.67(4),494-500(2002)
Gu, M., Iravani, M.M., Cooper, J.M., et al.Pramipexole protects against apoptotic cell death by non-dopaminergic mechanismsJ. Neurochem.91(5),1075-1081(2004)
Cheah, B.C., and Kiernan, M.C.Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosisIDrugs.13(12),911-920(2010)
